Thermotherapy of Buruli Ulcer at Community Level in the Health District of Akonolinga — UB Thermo  

Buruli Ulcer Clinical Trial

Official title: Thermotherapy of Buruli Ulcer at Community Level in the Health District of Akonolinga

Status Withdrawn

Clinical Trial Summary

The project rolls out combined innovative low-tech thermotherapy of Buruli ulcer (BU) with heat packs and WHO recommended wound management in a BU endemic district of Cameroon.

Clinical Trial Description

The project translates available clinical research findings at the secondary health care level into clinical practice at the primary health care and community level. The string of previous work from the development of the BU thermotherapy-wound management-package to the proof of its efficacy provides all necessary procedures, tools and documents to immediately proceed into practical and integrated community application. Main objective: To determine in patients with early BU lesions the effectiveness and acceptability of thermotherapy treatment at health post and community level. Specific objectives: 1. To monitor and evaluate clinical and biological responses to thermotherapy in patients receiving up to 8 weeks of thermotherapy 2. To assess within 6 months after completion of heat treatment wound closure ("primary cure") and/or absence of BU specific features in included patients according to WHO healing criteria 3. To measure the BU recurrence rate in included patient within 12 months after completion of heat treatment' ("definite cure"). 4. To assess the compliance rate of included patients 5. To assess the withdrawal rate of included patients 6. To assess the ability and comfort of health personnel to use the thermotherapy device ;

Related Conditions & MeSH terms

• Buruli Ulcer
• Ulcer

• NCT number: NCT03969940
• Study type: Observational
• Source: Swiss Tropical & Public Health Institute
• Status: Withdrawn
• Start date: January 1, 2019
• Completion date: June 30, 2020